Check out our @NEJM reply:
2 to collaterals, the acutely occluded MCA territory is almost never 300 ml
"unrestrictedly" large infarct applies as patients were not excluded 2 to infarct size & LASTE reflects real world distribution of large core < 6.5 hrs
https://t.co/6wYFimyAsj
We finally reached the summit 🏔️⛏️ in July on a final push 🧗♀️ towards 100% patient recruitment!!!
Congratulations to the entire team on this incredible achievement and gratitude 🙏🏼 to all participants!
We are so proud and looking forward to the results.
Another excellent workshop with medical doctors from Austria 🇦🇹🏔️🏰 took place in our NeuroAngio @UniSpitalBasel
After detailed theory sessions, we had the chance to practice endovascular treatment techniques 🧠 using our @Mentice Simulator and two flow models @WallabyPhenoxUS
💥What a magnificent way to connect people from around the🌍during the #ESOC2024 congress!
Twenty NeuroBallers🏀fighting for the golden 🍫 trophy
Looking forward to the rematch next year in Helsinki🤩
@ESOstroke@UniSpitalBasel@MPeyT1@TorstenRackoll@Giu_Reale @GregMakris23
How to treat medium distal vessel occlusions? Our DISTAL trial will provide evidence. Results expected in 2025. Stay tuned! @MPeyT1 @ESOstroke @esmintsociety https://t.co/5CKciAexJT
Join the #DISTALsummit to learn from experts in MeVO and DVO stroke.
https://t.co/D9Rb8YOR2u
Prof. Frédéric Clarençon from Paris is going to talk about the currently running randomized controlled trials and patient selection.
@ESOstroke@esmintsociety@MPeyT1@FishingNeurons